# Medpace Holdings, Inc.: filings

MEDP · Nasdaq · CIK 1668397 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/medp.md) · [Financials](/companies/medp/financials.md) · [Filings](/companies/medp/filings.md) · [Insiders](/companies/medp/insiders.md)

## Reports and events: 175 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 545, 8-K 90, 144 80, 10-Q 31, SC 13D/A 26, 3 23, SC 13G/A 16, UPLOAD 11, 10-K 10, 424B7 10, CORRESP 10, DEF 14A 10, DEFA14A 10, 4/A 7, ARS 4, DRSLTR 4, SC 13G 4, 144/A 3, EFFECT 3, SCHEDULE 13D/A 3, SC TO-T/A 3, DRS/A 2, FWP 2, PRE 14A 2, S-1/A 2, S-3/A 2, S-3ASR 2, SC 13D 2, 424B4 1, 8-A12B 1, CERTNAS 1, DRS 1, POS AM 1, S-1 1, S-3 1, S-8 1, SC 14D9 1, SC 14D9/A 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 16:02 ET | [10-Q](/filings/0001668397-26-000036.md) | Quarterly report, period 2026-09-30 | 0001668397-26-000036 |
| 2026-10-21 | 16:15 ET | [8-K](/filings/0001668397-26-000034.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001668397-26-000034 |
| 2026-09-28 | 19:15 ET | [SCHEDULE 13D/A](/filings/0001193125-26-405684.md) | Ownership report, active investor, amended | 0001193125-26-405684 |
| 2026-07-23 | 16:03 ET | [10-Q](/filings/0001668397-26-000025.md) | Quarterly report, period 2026-06-30 | 0001668397-26-000025 |
| 2026-07-22 | 16:15 ET | [8-K](/filings/0001668397-26-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001668397-26-000023 |
| 2026-06-04 | 16:06 ET | [8-K](/filings/0001193125-26-257387.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-257387 |
| 2026-05-19 | 14:43 ET | [8-K](/filings/0001193125-26-230425.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-230425 |
| 2026-04-23 | 16:03 ET | [10-Q](/filings/0001668397-26-000019.md) | Quarterly report, period 2026-03-31 | 0001668397-26-000019 |
| 2026-04-22 | 16:15 ET | [8-K](/filings/0001668397-26-000017.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001668397-26-000017 |
| 2026-04-01 | 16:38 ET | [DEF 14A](/filings/0001668397-26-000012.md) | Proxy statement, period 2026-05-15 | 0001668397-26-000012 |
| 2026-02-10 | 16:03 ET | [10-K](/filings/0001668397-26-000006.md) | Annual report, period 2025-12-31 | 0001668397-26-000006 |
| 2026-02-09 | 16:15 ET | [8-K](/filings/0001668397-26-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001668397-26-000004 |
| 2025-12-01 | 20:35 ET | [SCHEDULE 13D/A](/filings/0001193125-25-304263.md) | Ownership report, active investor, amended | 0001193125-25-304263 |
| 2025-10-23 | 16:03 ET | [10-Q](/filings/0001668397-25-000110.md) | Quarterly report, period 2025-09-30 | 0001668397-25-000110 |
| 2025-10-22 | 16:15 ET | [8-K](/filings/0001668397-25-000108.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001668397-25-000108 |
| 2025-07-22 | 16:07 ET | [10-Q](/filings/0001668397-25-000087.md) | Quarterly report, period 2025-06-30 | 0001668397-25-000087 |
| 2025-07-21 | 16:15 ET | [8-K](/filings/0001668397-25-000085.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001668397-25-000085 |
| 2025-05-16 | 17:11 ET | [8-K](/filings/0001193125-25-121801.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-121801 |
| 2025-04-22 | 16:02 ET | [10-Q](/filings/0001668397-25-000059.md) | Quarterly report, period 2025-03-31 | 0001668397-25-000059 |
| 2025-04-21 | 16:15 ET | [8-K](/filings/0001668397-25-000056.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001668397-25-000056 |
| 2025-04-02 | 17:02 ET | [DEF 14A](/filings/0001668397-25-000043.md) | Proxy statement, period 2024-12-31 | 0001668397-25-000043 |
| 2025-03-31 | 16:14 ET | [8-K](/filings/0001668397-25-000037.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001668397-25-000037 |
| 2025-03-11 | 21:30 ET | [SCHEDULE 13D/A](/filings/0000950170-25-037589.md) | Ownership report, active investor, amended | 0000950170-25-037589 |
| 2025-02-11 | 16:03 ET | [10-K](/filings/0001668397-25-000017.md) | Annual report, period 2024-12-31 | 0001668397-25-000017 |
| 2025-02-10 | 16:15 ET | [8-K](/filings/0001668397-25-000012.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001668397-25-000012 |
| 2024-10-22 | 16:02 ET | [10-Q](/filings/0001668397-24-000168.md) | Quarterly report, period 2024-09-30 | 0001668397-24-000168 |
| 2024-10-21 | 16:15 ET | [8-K](/filings/0001668397-24-000165.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001668397-24-000165 |
| 2024-07-23 | 16:03 ET | [10-Q](/filings/0001668397-24-000143.md) | Quarterly report, period 2024-06-30 | 0001668397-24-000143 |
| 2024-07-22 | 16:16 ET | [8-K](/filings/0001668397-24-000140.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001668397-24-000140 |
| 2024-07-03 | 16:37 ET | [8-K](/filings/0001193125-24-175077.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-175077 |
| 2024-05-21 | 16:05 ET | [8-K](/filings/0001193125-24-143907.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-143907 |
| 2024-04-23 | 16:02 ET | [10-Q](/filings/0001668397-24-000091.md) | Quarterly report, period 2024-03-31 | 0001668397-24-000091 |
| 2024-04-22 | 16:15 ET | [8-K](/filings/0001668397-24-000089.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001668397-24-000089 |
| 2024-04-03 | 16:17 ET | [DEF 14A](/filings/0001668397-24-000082.md) | Proxy statement, period 2024-05-17 | 0001668397-24-000082 |
| 2024-03-29 | 16:35 ET | [8-K](/filings/0001668397-24-000066.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001668397-24-000066 |
| 2024-03-08 | 16:28 ET | [SC 13D/A](/filings/0001193125-24-063698.md) | Ownership report, active investor, amended | 0001193125-24-063698 |
| 2024-02-28 | 17:04 ET | [SC 13D/A](/filings/0001193125-24-050841.md) | Ownership report, active investor, amended | 0001193125-24-050841 |
| 2024-02-13 | 16:02 ET | [10-K](/filings/0001668397-24-000013.md) | Annual report, period 2023-12-31 | 0001668397-24-000013 |
| 2024-02-12 | 16:15 ET | [8-K](/filings/0001668397-24-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001668397-24-000008 |
| 2023-12-05 | 16:15 ET | [SC 13D/A](/filings/0001193125-23-289164.md) | Ownership report, active investor, amended | 0001193125-23-289164 |
| 2023-10-24 | 16:02 ET | [10-Q](/filings/0001668397-23-000048.md) | Quarterly report, period 2023-09-30 | 0001668397-23-000048 |
| 2023-10-23 | 16:15 ET | [8-K](/filings/0001668397-23-000046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001668397-23-000046 |
| 2023-09-22 | 06:10 ET | [SC 13D/A](/filings/0001193125-23-239996.md) | Ownership report, active investor, amended | 0001193125-23-239996 |
| 2023-07-25 | 16:02 ET | [10-Q](/filings/0001668397-23-000043.md) | Quarterly report, period 2023-06-30 | 0001668397-23-000043 |
| 2023-07-24 | 16:15 ET | [8-K](/filings/0001668397-23-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001668397-23-000040 |
| 2023-05-19 | 16:03 ET | [8-K](/filings/0001668397-23-000036.md) | 5.07 Shareholder vote results | 0001668397-23-000036 |
| 2023-04-25 | 16:03 ET | [10-Q](/filings/0001668397-23-000033.md) | Quarterly report, period 2023-03-31 | 0001668397-23-000033 |
| 2023-04-24 | 16:15 ET | [8-K](/filings/0001668397-23-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001668397-23-000029 |
| 2023-04-05 | 16:17 ET | [DEF 14A](/filings/0001668397-23-000023.md) | Proxy statement | 0001668397-23-000023 |
| 2023-03-31 | 16:05 ET | [8-K](/filings/0001668397-23-000012.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001668397-23-000012 |

Page 1 of 4. [Older](/companies/medp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 15:38 ET. No prices; not investment advice.